In Re Rosuvastatin Calcium Patent Litigation
In Re Rosuvastatin Calcium Patent Litigation
Opinion
NOTE: ThiS order is nonprecedential ` United States Court of AppeaIs for the FederaI Circuit 1N RE R0SUvAsrrAT1N cA_Lc1UM PATENT L1'r1GATI0N - z.»”§sTEQziszi§fi§E;1zji§j}:Ii1§&iW'fED§i jIi'RW j PHARMAcEUT1cALs 1Nc.,AND sH10N0G1 SEIYAKU KABUSHIKI KAISHA, Plain,tiffs-Appellees, _ V. AUROBINDO PHARMA LIMITED, ' Defen,dcznt-Appellcmt, and MYLAN PHARMACEU'I`ICALS INC., Defen,dant-Appellant, and APOTEX CORP., Defendo:nt-Appellant, and COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendo:nts-Appellants, and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendan,t-Appellant,
ASTRAZENECA V. AUROBINDO 2 and TEVA PI~IARMACEUTICALS USA, INC., Defendcmt-Appellcmt, and PAR PHARMACEUTICAL, INC., Defendo;n,t-Appellant, and SANDOZ, INC., Defendar,t. 2010-1460, -1461, -1462, -1463, -146-<i, -1465, -1466, -1467, -1468, -1469, -147O, -1471, -1472, -1473 Appeals from the United States District Court for the District of DelaWare in case nos. 08-MD-1949, O7-CV- 081O, 07-CV-O805, 07-CV-O809, 07-CV-()811, 07-CV-0806, 08-CV-0426, and 07-CV-08[)8, Judge Joseph J. Farnan, Jr. ON MOTION ORDER Apotex Corp. moves for separate oral argument with respect to an issue in these appeals. Upon consideration thereof, IT ls 0R1;)ERE1) THAT: The motion is deferred for consideration by the merits panel assigned to hear this case. Copies of this order, the motion and any response shall be transmitted to the merits panel.
3 ma 24 2011 Date cc: Charles E. Lipsey, Esq. Robert B. Breisblatt, Esq. Jeffrey S. Ward, Esq. Steven A. l\/[add0x, Esq. William A. Rakoczy, Esq. Dutch Chung, Esq. James F. Hurst, Esq. Jeff`ry M. Nich0ls, Esq. s21 AsTRAzENEoA v. AURoB1Noo FoR THE CoURT /sf J an Horbaly Jan Horbaly Clerk 5 aE §*= §§ =l § U.3. COU THE FEDERA HAR 24 2011 lMlHDRBALY 0LER(
Reference
- Status
- Unpublished